Last reviewed · How we verify
NCT03371537: DEBIFOIE
Study of Hemodynamic Conditions Measured During Hepatectomy
trial testing Liver debit measure in Liver Dysfunction in 9 participants. Completed in 19 March 2019.
19 March 2019
Quick facts
| Lead sponsor | University Hospital, Tours |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 9 |
| Start date | 8 October 2017 |
| Primary completion | 19 March 2019 |
| Estimated completion | 19 March 2019 |
| Sites | 1 location across France |
Drugs / interventions tested
- Liver debit measure
Conditions studied
- Liver Dysfunction — all drugs for Liver Dysfunction →
- Circulatory; Change — all drugs for Circulatory; Change →
Sponsor
University Hospital, Tours
Who can join
18 and older, any sex, with Liver Dysfunction or Circulatory; Change. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hepatocellular insufficiency is a dreaded complication after hepatectomy, since, if it is persistent, it leads to the death of the patient in the absence of liver transplantation. The preoperative evaluation aims in particular to estimate the risk of postoperative hepatocellular insufficiency so as to minimize or contraindicate high-risk patients. It has been shown that the flow of the portal vein is correlated with liver function, especially in the living donor and after portal embolization. More recently, the study of flow rates in the portal vein and the hepatic artery after transplantation has shown a correlation with the recovery of graft function. The hypothesis is that portal and arterial flow after hepatectomy can predict postoperative hepatocellular function.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03371537
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Liver Dysfunction
Currently open trials in the same condition.
- NCT06173947 — SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury · recruiting
- NCT06532214 — Clinical Retrospective Study Analysis of Postoperative Complications Following Hepatectomy · recruiting
- NCT05793203 — Single-center Prospective Study of Non-invasive Methods for the Diagnosis of Postoperative Complications in Liver Transp · recruiting
- NCT03519074 — Cisplatin Combined with Oral TS-1 in Patients with Advanced Solid Tumors with Different Degrees of Liver Dysfunction · Phase 2 · active not recruiting
Other University Hospital, Tours trials
Trials by the same sponsor.
- NCT07452978 — Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence · Phase 2 · not yet recruiting
- NCT07443800 — Comorbidity Between Attention Deficit Hyperactivity Disorder and Fibromyalgia · NA · not yet recruiting
- NCT07251530 — Communication Enhancement Among Ventilated Patients in Intensive Care · not yet recruiting
- NCT07189338 — Apneic Oxygenation With High-flow Nasal Oxygenation After Preoxygenation With Noninvasive Ventilation Before Intubation · NA · not yet recruiting
- NCT07054112 — Efficacy of Live Online Course Mindfulness Program on Perceived Fatigue in Hemodialysis Patients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03371537 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Tours
- Last refreshed: 18 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03371537.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing